News

Press Release: Veterans Exploring Treatment Solutions (VETS) Leads Legislative Day of Action on March 18, 2025 in Support of Texas Ibogaine Initiative

The Legislative Day of Action aims to educate legislators on the transformative potential of ibogaine-assisted therapy for veterans struggling with OUD, co-occurring SUD, and neurological or mental health conditions, as well as address the critical issue that service members must travel internationally to access these treatments.

Boulder Weekly: BIFF marches on Four picks to make the most of this year’s fest

The Boulder International Film Festival (BIFF) returns for its 21st year, offering a diverse lineup of films that promise to captivate audiences. This year's festival highlights include The Friend, a heartfelt drama featuring Naomi Watts and Bill Murray; The White House Effect, a gripping archival documentary on climate policy; In Waves and War, an exploration of psychedelic therapy for veterans; and One to One: John & Yoko, a deep dive into John Lennon’s final concert. With over 60 films to discover, BIFF continues to celebrate storytelling in all its forms.

The Microdose: New California bills focus on veterans; the State of Psychedelics; Death penalty for dealers?

​California is advancing new legislation aimed at supporting veterans and exploring the therapeutic potential of psychedelics. These bills seek to enhance mental health treatment options for veterans by potentially decriminalizing certain psychedelic substances and funding research into their efficacy for conditions like PTSD. Advocacy groups, such as the Heroic Hearts Project, have been instrumental in promoting these initiatives, emphasizing the need for alternative therapies

CBS News: With RFK Jr. in charge, supplement makers see chance to cash in

As Robert F. Kennedy Jr. takes charge of the Department of Health and Human Services, supplement makers see a major opportunity to expand their influence. With his skepticism of pharmaceutical regulation and a push for "health freedom," the industry aims to make bolder claims, secure government subsidies, and loosen FDA oversight. Advocates praise the shift, while critics warn of the risks posed by unproven treatments.

Salon: A psychedelic plant from Africa holds promise for addiction and trauma — but it's not for everyone.

Despite being illegal in the U.S., ibogaine popularity is growing. Here's why this shrub can potentially heal